Y-mAbs Therapeutics Free Cash Flow (Quarterly) Analysis

Y-mAbs Therapeutics Inc (YMAB)

17.26 +0.77 (+4.67%) USD | NASDAQ | May 02, 16:00

16.92 -0.34 (-1.97%) Pre-Market: 20:00

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	-8.036M
September 30, 2023	-1.338M
June 30, 2023	-4.734M
March 31, 2023	-13.12M
December 31, 2022	-8.661M
September 30, 2022	-19.24M
June 30, 2022	-23.10M
March 31, 2022	-24.92M
December 31, 2021	-34.32M
September 30, 2021	-18.15M
June 30, 2021	-18.80M
March 31, 2021	-32.26M

Date	Value
December 31, 2020	-17.74M
September 30, 2020	-24.25M
June 30, 2020	-27.64M
March 31, 2020	-21.78M
December 31, 2019	-25.73M
September 30, 2019	-22.01M
June 30, 2019	-14.12M
March 31, 2019	-13.61M
December 31, 2018	-13.63M
September 30, 2018	-9.241M
June 30, 2018	-11.98M
March 31, 2018	-6.608M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-34.32M

Minimum

Dec 2021

-1.338M

Maximum

Sep 2023

-18.94M

Average

-19.24M

Median

Sep 2022

Free Cash Flow (Quarterly) Benchmarks